Successful omalizumab treatment in chronic spontaneous urticaria is associated with lowering of serum IL-31 levels.

Altrichter S1, Hawro T1, Hänel K2,3, Czaja K2, Lüscher B3, Maurer M1, Church MK1, Baron JM2.
Author information
1
Department of Dermatology and Allergology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
2
Department of Dermatology and Allergology, Medical School RWTH Aachen University, Aachen, Germany.
3
Medical School RWTH Aachen University, Institute of Biochemistry and Molecular Biology, Aachen, Germany.
PMID: 25371135 DOI: 10.1111/jdv.12831
J Eur Acad Dermatol Venereol. 2016 Mar;30(3):454-5. doi: 10.1111/jdv.12831. Epub 2014 Nov 4.